Abstract
AbstractBlood analysis is crucial for early cancer screening and improving patient survival rates. However, developing an effective strategy for early cancer detection using high‐throughput blood analysis is still challenging. Herein, a novel automatic super‐hydrophobic platform is developed together with a deep learning (DL)‐based label‐free serum and surface‐enhanced Raman scattering (SERS), along with an automatic high‐throughput Raman spectrometer to build an effective point‐of‐care diagnosis system. A total of 695 high‐quality serum SERS spectra are obtained from 203 healthy volunteers, 77 leukemia M5, 94 hepatitis B virus, and 321 breast cancer patients. Serum SERS signals from the normal (n = 183) and patient (n = 443) groups are used to assess the DL model, which classify them with a maximum accuracy of 100%. Furthermore, when SERS is combined with DL, it exhibits excellent diagnostic accuracy (98.6%) for the external held‐out test set, indicating that this method can be used to develop a high throughput, rapid, and label‐free tool for screening diseases.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
